Samsung Pharmaceutical Co., Ltd. completed the sale of 17.13% stake in Medizen Humancare Co.,Ltd.
Samsung Pharmaceutical Co., Ltd. (KOSE:A001360) completed the sale of 17.13% stake in Medizen Humancare Co.,Ltd. on October 5, 2015.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,190 KRW | -3.71% | +2.77% | +29.75% |
1st Jan change | Capi. | |
---|---|---|
+29.75% | 90.57L | |
-41.39% | 827.06Cr | |
+3.25% | 335.41Cr | |
-0.37% | 234.22Cr | |
-19.19% | 201.67Cr | |
-22.57% | 161.69Cr | |
+32.82% | 116.23Cr | |
-8.30% | 71Cr | |
+14.12% | 70Cr | |
-31.22% | 49Cr |